55 Greens Farms Road
1st Floor
Westport, CT 06880
United States
203 409 5444
https://www.biosig.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 47
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Frederick D. Hrkac | President, Principal Executive Officer & Executive VP | 15k | N/A | 1967 |
Dr. Budimir S. Drakulic Ph.D. | Chief Scientist | 169.64k | N/A | 1950 |
Mr. Andrew Gornell Ballou | Vice President of Investor Relations | N/A | N/A | N/A |
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
BioSig Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.